- 07 Jun 2017
- Research & Ideas
How an African History Scholar Became a Modern Righter of Wrongs
A scholar of colonial-era African history, Caroline M. Elkins had dramatic success turning prior knowledge into real-world action—namely, with a groundbreaking lawsuit against the British government, which revealed a chillingly bureaucratic process for destroying evidence of torture. Open for comment; 0 Comments.
- 20 Apr 2017
- Cold Call Podcast
Making Health Insurance That Consumers Actually Like
By motivating its insurance customers to take care of themselves, South African firm Vitality has expanded to the United Kingdom and China. In this podcast, Professor Regina Herzlinger discusses potential impacts of this model for health care in the United States. Open for comment; 0 Comments.
- 28 Sep 2015
- Research & Ideas
Six Lessons from Mobile Money Ventures in Developing Countries
Improving access to financial services for the poor in developing countries seems an unmet market need. So why are so many mobile money efforts failing? Rajiv Lal says the problem begins with Marketing 101. Open for comment; 0 Comments.
- 06 Nov 2006
- Research & Ideas
How South Africa Challenges Our Thinking on FDI
After the fall of apartheid, South Africa accepted the standard prescription for countries to receive more foreign direct investment. Yet FDI has been a mere trickle. Why? The answer may reside in the country's strong corporate environment, says HBS professor Eric D. Werker. Key concepts include: South Africa has received just a fraction of the foreign direct investment experienced by other comparable emerging-market economies, challenging some standard views about how FDI works. After apartheid, South African conglomerates had money to invest as well as a large market share within their industry. Foreign firms or asset managers who want exposure to South Africa might simply choose to go through financial markets. A major test of South Africa's infrastructure and security will be World Cup soccer in 2010. Closed for comment; 0 Comments.
Could a Business Model Help Big Pharma Save Lives and Profit?
Gilead Sciences used a novel approach to help Egypt address a public health crisis while sustaining profits from a key product. V. Kasturi Rangan and participants at a recent seminar hosted by the Institute for the Study of Business in Global Society discussed what it would take to apply the model more widely.